Belgium· BE-AMP-SAM489662-00
Dexamethasone Bipharma 1 mg/ml
A dexamethasone product containing dexamethasone sodium phosphate, registered in Belgium by Bipharma. The same ATC class is registered in 13 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Dexamethasone is registered in 13 of 19 countries.
Countries holding a registration under ATC S01BA01 (dexamethasone), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Dexamethasone · ATC S01BA01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dexamethasone costs, country by country.
Normalised to the WHO defined daily dose (0.2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dexamethasone · price per daily dose (0.2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$362.24
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Dexamethasone Sodium Phosphate
- Manufacturer
- Bipharma
- Country
- Belgium (BE)
- ATC code
- S01BA01
- ATC class
- Dexamethasone
- Defined daily dose
- 0.2 mg, AT
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
96 interactions on record for dexamethasone.
Graded by severity as the source publishes them — 41 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dexamethasone · interactions on record
96 records
- 41 moderate
- 55 minor
Most severe, free to view
- MiconazoleA07AC01moderate
- LonafarnibA16AX20moderate
- VoxelotorB06AX03moderate
- ConivaptanC03XA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dexamethasone in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAxiumoptoUni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.
- CzechiaDARAZURPharmaselect International Beteiligungs GmbH, Vídeň
- SwedenOpnol 1 mg/ml Ögondroppar, lösning i endosbehållareKaro Pharma AB
- United StatesDexamethasone Sodium PhosphateBausch & Lomb Incorporated
- GermanyDexaMibe Gmbh Arzneimittel
- IrelandDexamethasone phosphate 4 mg/ml solution for injectionFresenius Kabi Deutschland GmbH
- NorwayDexa-sine SEImmedica Pharma AB
- CanadaDEXAMETHASONEPHARMA STULLN INC.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Dexabene, Dexagel
- Bulgaria · Dexason, Дексамед
- Cyprus · Dexamethasone [pf] Rafarm, Dexamethasone Medochemie
- Czechia · Darazur, Dexamethasone Galenika
- Germany · Dexa Jenapharm, Dexa Mibe
- Denmark · Dexamethasone Phosphate "hameln", Dexamethasone Phosphate Noridem
- Estonia · Dexagel, Dexamethasone Kabi
- Spain · Colircusí, Dexametasona Kern Pharma
- Finland · Dexamethasone Phosphate Hameln, Dexamethasone Phosphate Kabi
- France · Etartilen
- United Kingdom (Northern Ireland) · Dexamethasone, Dexamethasone Aspen Pharma Trading Limited
- Greece · Dexamethasone /Kabi, Dexamethasone G.A.P.
- Croatia · Deksametazon Galenika, Deksametazon Hameln
- Hungary · Dexa, Dexametazon Hameln
- Ireland · Dexamethasone, Dexamethasone Phosphate As Kalceks
- Iceland · Dexamethasone Hameln, Dexamethasone Teva
- Italy · Cortmuper, Decadron
- Lithuania · Dexal, Dexamethasone Phosphate Medochemie
- Luxembourg · Dexa Ratiopharm, Spersadex
- Latvia · Dexagel, Dexamethasone Unifarma
- Netherlands · Dexa-Pos, Dexamethason Cf
- Norway · Dexamethasone Phosphate Hameln, Dexamethasone Phosphate Noridem
- Poland · Demezon, Demezon, 8 Mg/Ml, Roztwór Do Wstrzykiwań
- Portugal · Dexametasona Galenika, Dexametasona Hameln
- Romania · Dexamed, Dexametazonă Fosfat Galenika
- Sweden · Dexamethasone Fresenius Kabi, Dexavit
- Slovenia · Deksametazon Galenika, Deksametazon Hameln
- Slovakia · Dexamed, Dexamethasone Galenika
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ddb47dc2-3376-4b9c-a2e2-db4c1eaa9377 GET /v1/drugs/ddb47dc2-3376-4b9c-a2e2-db4c1eaa9377?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye drops, solution in single-dose container",
"source": "afmps",
"status": "REVOKED",
"name_en": "Dexamethasone Bipharma 1 mg/ml",
"name_fr": "Dexamethasone Bipharma 1 mg/ml",
"name_nl": "Dexamethasone Bipharma 1 mg/ml",
"amp_code": "SAM489662-00",
"strengths": [
"1.1000",
"1.1000",
"1.0000",
"1.0000",
"1.0000",
"9.5000",
"6.0000"
],
"pack_count": 5,
"substances": [
"Dexamethasone Sodium Phosphate",
"Dexamethasone Phosphate",
"Disodium Edetate",
"Disodium Hydrogen Phosphate Dodecahydrate",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Dexamethasone",
"authorisation_numbers": [
"BE489662"
]
}See everything about dexamethasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.